Clinical trial
Safety and Effectiveness of Edwards Lifesciences SAPIEN XT Transcatheter Heart Valve in the Chinese Population
NCT03314857 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of Edwards Lifesciences SAPIEN XT Transcatheter Heart Valve in the Chinese Population
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 18, 2017
- Completion date
- June 15, 2023
- Enrollment
- 67 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
aortic regurgitation, aortic stenosis, symptomatic aortic stenosis